Explore more publications!

Healthcare Wire Texas: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Wire Texas.

Press releases published on March 17, 2026

HealthWorks Family Chiropractic Hosts Free Women’s Hormone Workshop in Plano on March 26th
Cloud-Clone ELISA Kit Supports Landmark Nature Medicine Discovery of Novel IPAH Biomarker
Organoid COMMONS Announces Formation of Governing Board, Appointment of Alliance Director, and Announces Open Call for New COMMONS Members
Cognition Therapeutics Presents Evidence of Zervimesine’s Impact on Neuropsychiatric Symptoms of Dementia with Lewy Bodies at AD/PD 2026
Anavex Life Sciences Presents Significant Treatment Effects of Blarcamesine in New Advanced Alpha-Synuclein Model of Parkinson’s Disease at AD/PD 2026 Conference
Abeona Therapeutics® Reports Full Year 2025 Financial Results and Corporate Updates
Thérapeutique Knight annonce la soumission d’une indication supplémentaire pour le lymphome folliculaire pour MINJUVI® (tafasitamab) en Argentine et au Mexique
Knight Therapeutics Announces Regulatory Supplemental Submission of MINJUVI® (tafasitamab) for Follicular Lymphoma in Argentina and Mexico
MiNK Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Highlight Platform Expansion Across iNKT Cell Therapy Programs
CervoMed Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Updates
Kane Biotech Announces Publication in Frontiers in Antibiotics Highlighting Advancements in Treating Antibiotic Tolerant Biofilms
R1 Therapeutics launches with oversubscribed $77.5 million Series A financing to advance first-in-class treatment for hyperphosphatemia in patients with chronic kidney disease
IgNS and ACHC Launch New Distinction to Elevate Standards in Immunoglobulin Therapy
Transpire Bio Strengthens its Leadership Team with Appointment of Ewan Livesey as Head of Business Development
Fractyl Health to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Updates on March 24, 2026
Endogenex Announces Publication of REGENT-1 Clinical Study Results in Diabetes, Obesity and Metabolism
Monte Rosa Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial Results and Business Updates
Picard Medical / SynCardia Announce Successful Four-Year Bridge to Transplant with SynCardia Total Artificial Heart Support
Vireo Growth Inc. Announces Fourth Quarter 2025 Results
Asimov Announces Cell Line Development Partnership with Score Pharma to Advance Biosuperior Antibody Therapeutics

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions